Schedule 13G ownership disclosure
Zyla Life Sciences
Security class unavailable · CUSIP: 98986F108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 935,161
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001163648-20-000009
- Form type
- SC 13G
- Filer
- CI INVESTMENTS INC.
- CIK
- CIK 1163648
- Filed
- Feb 13, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership